Michelle Graham joins MBX Biosciences as CHRO

MBX Biosciences, a US-based biopharmaceutical company, has announced the appointment of Michelle Graham as the new Chief Human Resources Officer, with immediate effect. 

Assuming her new role Graham, who was heading HR operations at Albireo Pharma as CHRO, brings more than 25 years of talent management expertise to the pharma industry. Before this, she held the position of Senior VP and CHRO at GSK’s acquired biotech firm TESARO Inc.  She also held a key role at Parexel International Corp. as Corporate VP and CHRO. Earlier in her career, she held senior leadership roles as VP of HR at Bausch + Lomb, Senior VP of HR at Greatbatch Inc. and Senior Director of Bristol-Myers Squibb.

Welcoming Graham in her new role, Kent Hawryluk, President and CEO of MBX Biosciences said, “Michelle is an exceptionally experienced human resources executive with an impressive track record of leading global teams, developing and executing HR strategies, and fostering a diverse and inclusive culture. Her breadth of experience building and supporting biopharma companies at various stages of development will be highly impactful as we are poised to enter an exciting growth phase for the Company. We are pleased to welcome Michelle to MBX and look forward to leveraging her expertise.”

Graham shared, “I am pleased to join the impressive MBX Biosciences team at this pivotal time in the company’s trajectory. MBX has a strong patient-centered culture, and I look forward to supporting the continued growth of the organization in advancing its Precision Endocrine Peptide platform and ultimately serving patients in need.”